Literature DB >> 1773235

The diagnosis of dementia in the elderly. A comparison of CAMCOG (the cognitive section of CAMDEX), the AGECAT program, DSM-III, the Mini-Mental State Examination and some short rating scales.

G Blessed1, S E Black, T Butler, D W Kay.   

Abstract

The performance of CAMCOG, the cognitive section of the CAMDEX, is compared in a non-random sample of 222 elderly people with diagnoses based on AGECAT and on DSM-III criteria, and with the MMSE and some short rating scales. With a cut-off point of 69/70 and AGECAT organic syndrome as the criterion, the sensitivity of CAMCOG was 97% and the specificity 91%. However, 21% of DSM-III diagnoses of dementia scored above this cut-off; these were mostly mild cases. The correlation between CAMCOG and MMSE scores was 0.87, and the advantage of CAMCOG may be more apparent in longitudinal studies. Multivariate analyses showed that CAMCOG scores are affected by age, sociocultural factors and hearing and visual deficits in addition to dementia, but not by depression. There was a suggestion that individual subsections are differentially affected.

Entities:  

Mesh:

Year:  1991        PMID: 1773235     DOI: 10.1192/bjp.159.2.193

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  9 in total

1.  The validity of cognitive testing in screening for dementia.

Authors:  P Stockton; J Cohen-Mansfield; N Billig
Journal:  J Med Syst       Date:  1998-02       Impact factor: 4.460

2.  Brain stethoscopes: the use and abuse of brief mental status schedules.

Authors:  D O'Neill
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

3.  Risk factors and early signs of Alzheimer's disease in a family study sample. Risk of AD.

Authors:  Reinhard Heun; Heike Kölsch; Frank Jessen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-05-20       Impact factor: 5.270

4.  The prevalence and causes of dementia in people under the age of 65 years.

Authors:  R J Harvey; M Skelton-Robinson; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 5.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

6.  Clinical treatment reverses attentional deficits in congestive heart failure.

Authors:  O P Almeida; S Tamai
Journal:  BMC Geriatr       Date:  2001       Impact factor: 3.921

7.  The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.

Authors:  Michael S Rafii; Hannah Wishnek; James B Brewer; Michael C Donohue; Seth Ness; William C Mobley; Paul S Aisen; Robert A Rissman
Journal:  Front Behav Neurosci       Date:  2015-09-14       Impact factor: 3.558

8.  Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.

Authors:  Diane Mullins; Eileen Daly; Andrew Simmons; Felix Beacher; Catherine Ml Foy; Simon Lovestone; Brian Hallahan; Kieran C Murphy; Declan G Murphy
Journal:  J Neurodev Disord       Date:  2013-08-20       Impact factor: 4.025

Review 9.  Longitudinal course of behavioural and psychological symptoms of dementia: systematic review.

Authors:  Rianne M van der Linde; Tom Dening; Blossom C M Stephan; A Matthew Prina; Elizabeth Evans; Carol Brayne
Journal:  Br J Psychiatry       Date:  2016-08-04       Impact factor: 9.319

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.